tiprankstipranks
Trending News
More News >
Shigematsu Works Co., Ltd. (JP:7980)
:7980
Japanese Market

Shigematsu Works Co., Ltd. (7980) AI Stock Analysis

Compare
0 Followers

Top Page

JP:7980

Shigematsu Works Co., Ltd.

(7980)

Select Model
Select Model
Select Model
Outperform 82 (OpenAI - 5.2)
Rating:82Outperform
Price Target:
¥1,163.00
▲(48.53% Upside)
Action:ReiteratedDate:03/10/26
The score is driven by strong technical uptrend signals and an attractive low P/E valuation. Financial performance is solid on revenue growth and margins with a stable balance sheet, but it is tempered by negative free cash flow and weak cash generation from operations.
Positive Factors
Consistent revenue growth and healthy margins
Shigematsu's reported 8.6% revenue growth alongside a 31.4% gross margin and 12.6% EBITDA margin indicates steady end-market demand and effective cost control. These margins support reinvestment and operational resilience, helping sustain profitability over the 2-6 month horizon and beyond.
Solid balance sheet with moderate leverage
A debt-to-equity ratio of 0.59 and a 47.5% equity ratio show a stable capital structure with moderate leverage. ROE around 9.1% demonstrates reasonable returns on equity. This financial positioning provides flexibility to fund operations or absorb shocks without severe solvency stress in the medium term.
Defensive business model with recurring demand
As a PPE and respiratory-protection manufacturer, the company benefits from recurring consumable demand (filters, renewals) and institutional customers bound by safety regulations. This structural demand and customer stickiness supports predictable revenue streams and lowers long-term revenue volatility risks.
Negative Factors
Negative free cash flow and weak cash conversion
A -1.65 billion yen free cash flow and an operating-cash-to-net-income ratio of 0.29 indicate operations and capex are consuming cash. Persistent weak cash conversion limits internal funding for growth, dividends, or debt reduction, potentially forcing external financing and reducing strategic flexibility.
Increasing debt noted as a potential risk
The balance-sheet note about rising total debt signals growing leverage risk. With modest net margins and negative FCF, additional debt raises interest and refinancing exposure, could constrain capital allocation, and amplify downside in adverse demand or cost environments over the medium term.
Revenue exposed to cyclical industrial and public-health trends
Sales depend on industrial activity and episodic public-health demand, creating structural cyclicality. While baseline compliance purchases provide a floor, significant swings in industrial output or pandemic-driven spikes can produce revenue and utilization volatility, complicating medium-term planning.

Shigematsu Works Co., Ltd. (7980) vs. iShares MSCI Japan ETF (EWJ)

Shigematsu Works Co., Ltd. Business Overview & Revenue Model

Company DescriptionShigematsu Works Co., Ltd. manufactures and sells protective equipment in Japan. It offers protective clothing and gloves; eye protectors; reusable respirators; disposable respirators; powered air purifying respirators; supplied-air respirators; self-contained breathing apparatus; gas respirators/chemical cartridge respirators; face shields; earmuffs; safety belts; stretchers; and oxygen meters. The company is also involved in the manufacture and sale of instrument, chemical, and material related to safety and health, disaster-prevention in the plumbing and industrial fields. Shigematsu Works Co., Ltd. was founded in 1917 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyThe company primarily makes money by manufacturing and selling respiratory protection products and related PPE to corporate and institutional customers that need workplace safety equipment. Revenue is generated through product sales across its PPE lineup (with respiratory protection as the core), typically via distribution channels such as safety-equipment dealers and industrial supply networks, as well as direct sales to end users where applicable. Earnings are influenced by ongoing replacement demand (e.g., consumable filters and periodic product renewal), workplace safety compliance requirements, and fluctuations in industrial activity and public-health-driven demand for protective equipment. Specific breakdowns by segment, customer mix, pricing model, or named strategic partnerships: null.

Shigematsu Works Co., Ltd. Financial Statement Overview

Summary
Strong income statement (revenue growth 8.6%, gross margin 31.4%, EBITDA margin 12.6%) and a solid balance sheet (debt-to-equity 0.59, equity ratio 47.5%). The main drag is cash flow: negative free cash flow (-1.65B yen) and weak operating cash conversion (operating cash flow to net income 0.29).
Income Statement
85
Very Positive
Shigematsu Works Co., Ltd. has shown a strong revenue growth rate of 8.6% in the most recent year, with consistent improvements in gross and net profit margins. The gross profit margin stands at 31.4%, while the net profit margin is 5.5%, indicating efficient cost management and profitability. The EBITDA margin of 12.6% reflects a healthy operating performance. However, EBIT margin at 7.6% suggests room for operational cost optimization.
Balance Sheet
78
Positive
The company's balance sheet displays a solid equity base with a debt-to-equity ratio of 0.59, reflecting moderate leverage. The return on equity is 9.1%, indicating good profitability relative to shareholder investment. The equity ratio of 47.5% suggests a stable financial structure, though an increase in total debt from the previous year could be a potential risk factor if not managed properly.
Cash Flow
70
Positive
The cash flow analysis reveals a challenging year with a negative free cash flow of -1.65 billion yen, largely due to high capital expenditures. The operating cash flow to net income ratio of 0.29 indicates weaker cash generation from operations. The free cash flow to net income ratio is negative, highlighting the impact of capital investments on cash reserves, necessitating careful management of cash flow.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue14.08B14.11B13.00B12.88B11.92B12.70B
Gross Profit4.27B4.30B3.93B4.01B3.63B4.02B
EBITDA1.67B1.73B1.31B1.69B1.25B1.36B
Net Income665.87M780.58M584.08M748.24M589.11M651.05M
Balance Sheet
Total Assets17.98B18.17B16.22B15.32B14.32B13.98B
Cash, Cash Equivalents and Short-Term Investments1.46B1.48B1.63B1.63B1.35B1.53B
Total Debt4.84B5.04B3.12B3.13B3.36B3.45B
Total Liabilities9.32B9.61B7.94B7.97B7.83B8.37B
Stockholders Equity8.66B8.57B8.28B7.35B6.50B5.62B
Cash Flow
Free Cash Flow0.00-1.65B399.81M667.73M26.94M-328.40M
Operating Cash Flow0.00228.18M966.39M1.12B490.66M762.84M
Investing Cash Flow0.00-2.21B-838.81M-643.92M-496.46M-1.13B
Financing Cash Flow0.001.83B-125.72M-299.93M-173.66M399.23M

Shigematsu Works Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price783.00
Price Trends
50DMA
887.14
Positive
100DMA
837.03
Positive
200DMA
823.58
Positive
Market Momentum
MACD
46.68
Positive
RSI
54.98
Neutral
STOCH
19.45
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7980, the sentiment is Positive. The current price of 783 is below the 20-day moving average (MA) of 1013.90, below the 50-day MA of 887.14, and below the 200-day MA of 823.58, indicating a bullish trend. The MACD of 46.68 indicates Positive momentum. The RSI at 54.98 is Neutral, neither overbought nor oversold. The STOCH value of 19.45 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7980.

Shigematsu Works Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
82
Outperform
¥7.22B6.061.93%4.41%-16.07%
71
Outperform
¥148.57B18.722.73%5.10%-26.13%
68
Neutral
¥836.83B24.3311.64%0.82%13.53%-7.39%
63
Neutral
¥234.08B-69.02-2.06%2.66%5.43%-20.67%
62
Neutral
¥242.36B5.594.38%2.03%6.04%733.13%
54
Neutral
¥10.60B31.523.85%0.38%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7980
Shigematsu Works Co., Ltd.
1,015.00
200.09
24.55%
JP:7747
Asahi Intecc Co
3,154.00
779.03
32.80%
JP:7716
Nakanishi
2,773.00
598.13
27.50%
JP:8086
Nipro
1,486.00
164.60
12.46%
JP:7702
JMS Co., Ltd.
434.00
-34.69
-7.40%
JP:7730
Mani, Inc.
1,508.00
183.65
13.87%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 10, 2026